Lingyu Luo
1 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| Non Squamous NSCLC Patients With Anlotinib Combined With Pemetrexed and Cisplatin (NCT03671538) | Lingyu Luo | 2018-10-01 |
Track Lingyu Luo automatically
Every clearance here is in the API, with alerts when new ones post.